Why is Medincell stock plunging today?
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medincell SA (MEDCL)
Medincell SA stock price live, this page displays EPA MEDCL stock exchange data. View the MEDCL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medincell SA real time stock price chart below.
What Is the Medincell SA Stock Price Today?
The Medincell SA stock price today is 29.70.
What Is the Stock Symbol for Medincell SA?
The stock symbol for Medincell SA is "MEDCL."
What Stock Exchange Does Medincell SA Trade On?
Medincell SA is listed and trades on the Paris stock exchange.
Is Medincell SA a Good Stock to Buy?
Determining whether Medincell SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDCL quote. (ISIN: FR0004065605)
What Is the Medincell SA Stock Price Today?
The Medincell SA stock price today is 29.70.
What Is the Stock Symbol for Medincell SA?
The stock symbol for Medincell SA is "MEDCL."
What Stock Exchange Does Medincell SA Trade On?
Medincell SA is listed and trades on the Paris stock exchange.
Is Medincell SA a Good Stock to Buy?
Determining whether Medincell SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MEDCL quote. (ISIN: FR0004065605)
29.70
+0.18(+0.61%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.64
29.76
52 wk Range
15.39
39.68
MEDCL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.6429.76
52 wk Range
15.3939.68
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MEDCL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
34.51
Upside
+16.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 34.51
(+16.20% Upside)
Earnings
Latest Release
Jun 16, 2026
EPS / Forecast
-- / -0.15
Revenue / Forecast
-- / 6.4M
Compare MEDCL to Peers and Sector
Metrics to compare | MEDCL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDCLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −53.1x | 21.0x | −0.4x | |
PEG Ratio | −1.28 | 0.09 | 0.00 | |
Price/Book | −34.6x | 1.5x | 2.6x | |
Price / LTM Sales | 32.7x | 2.0x | 3.0x | |
Upside (Analyst Target) | 15.2% | 28.3% | 49.1% | |
Fair Value Upside | Unlock | 3.9% | 6.3% | Unlock |
MedinCell S.A., a clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France. The company develops solutions based on BEPO, a long-acting injectable technology. It offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults and bipolar I disorder. It is also developing mdc-TJK, a subcutaneous injection that is in the NDA preparation stage for the treatment of schizophrenia in adults; and mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation in total knee arthroplasty surgery. In addition, its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. It has strategic collaborations with AbbVie to develop, manufacture, and commercialize six long-acting injectable therapeutic products; and IM4TB to develop a long-acting injectable version of Macozinone for the treatment of tuberculosis. MedinCell S.A. was incorporated in 2003 and is based in Jacou, France.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Medincell (MEDCL) Stock Price Today?
The Medincell stock price today is 29.70 EUR.
What Stock Exchange Does Medincell Trade On?
Medincell is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Medincell?
The stock symbol for Medincell is "MEDCL."
What Is the Medincell Market Cap?
As of today, Medincell market cap is 1.06B EUR.
What Is Medincell's Earnings Per Share (TTM)?
The Medincell EPS (TTM) is -0.63.
When Is the Next Medincell Earnings Date?
Medincell will release its next earnings report on Sep 02, 2026.
From a Technical Analysis Perspective, Is MEDCL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Medincell Stock Split?
Medincell has split 0 times.
How Many Employees Does Medincell Have?
Medincell has 145 employees.
What is the current trading status of Medincell (MEDCL)?
As of Jul 06, 2026, Medincell (MEDCL) is trading at a price of 29.70 EUR, with a previous close of 29.52 EUR. The stock has fluctuated within a day range of 29.64 EUR to 29.76 EUR, while its 52-week range spans from 15.39 EUR to 39.68 EUR.
What Is Medincell (MEDCL) Price Target According to Analysts?
The average 12-month price target for Medincell is 34.51 EUR, with a high estimate of 39 EUR and a low estimate of 30 EUR. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +16.20% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.